Sorivudine is a potent nucleoside analogue antiviral agent used to inhibit DNA polymerase activity in herpes simplex virus type 1 and varicella-zoster virus infections. By functioning as a competitive… Read more
Sorivudine is a potent nucleoside analogue antiviral agent used to inhibit DNA polymerase activity in herpes simplex virus type 1 and varicella-zoster virus infections. By functioning as a competitive inhibitor of thymidine during viral DNA synthesis, this compound effectively disrupts the replication of these specific viruses. The accompanying range of reference standards, including sorivudine impurities, metabolites, and stable isotope-labelled compounds, plays a critical role in essential analytical procedures. These high-quality reference materials are indispensable for pharmaceutical laboratories conducting impurity profiling, method validation, and rigorous quality control. Utilizing these specific standards ensures precise quantification and characterization during the various stages of drug development and regulatory compliance, allowing researchers to maintain the highest standards of accuracy when analyzing the stability, safety, and efficacy of pharmaceutical formulations containing this antiviral agent.